NMPAR vs PFE
NMP Acquisition Corp. Right (NMPAR) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
NMP Acquisition Corp. Right (NMPAR) common stock listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
NMPAR does not have a complete income-statement cache yet.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
NMPAR currently screens at market cap $0. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the NMPAR and PFE stock pages for the full models.
Not investment advice.